January 17, 2020January 20, 2020 // CED News/Events CED Announces Venture Connect 2020 Presenting Companies RTP, NC January 17, 2020 – The Council for Entrepreneurial Development (CED) today announced the tech and life science companies that have been selected to present at Venture Connect Summit 2020, to be held March 17-19 in Raleigh, NC. Click here to view the profiles. “We had a record year this year with an overwhelming response in applications received. It’s going to be an amazing Summit with a building list of over 125 tech and life science companies on stage,” says Miriam Wison, SVP of CED. Companies will take the stage to present their big ideas in front of a captive audience and potential investors. Venture Connect is the future of tech and life science and an opportunity to grow brand awareness and gain valuable insight on educational topics. We expect over 1400 attendees, over 200 investors and countless valuable connections to be made. Presenting companies were chosen by a selection committee made up of community members, including active angel investors, local and regional venture capital firms, community and corporate partners. You will find a diverse selection of presenting companies at Venture Connect including: AI, Augmented Reality, Big Data, Cyber Security, E-Commerce, Smart Devices, Digital Health, Healthy Consumer, Therapeutics, Advanced Diagnostics, Med Device, Ag Tech and more. 2020 Venture Connect Presenting Companies: Adzerk Allstacks Applied LifeSciences and Systems Poultry, Inc. Arrevus Baebies, Inc. Cell Microsystems, Inc Cereius, Inc CrediVia Diveplane CorporationEasyVote Solutions Enzerna Biosciences, Inc Evecxia, Inc. EydisBio, Inc. Gavilan Biodesign Gemelli Biotech IMMvention Therapeutix, Inc Keen Decision Systems LearnPlatform Lindy Biosciences, Inc. Metabolon, Inc. Nufabrx NuPulseCV ProAxion Inc RFPI, Inc. SENTIO StrongKey Tellus Therapeutics, Inc. The Climate Service Veralox Therapeutics, Inc. Viatec, Inc. Voxelight LLC Wellnecity ZynBit 6AM City LLC Achelios Therapeutics Advanced Chemotherapy Technologies Advanced Nanocoatings Incorporated AgEye Technologies Altis Biosystems, Inc. AnelleO, Inc. Aniluxx Biotechnology Aptus Bioreactors Ares Immunotherapy Arpio Avior Bio Inc Basking Biosciences, inc Betr Health BioAesthetics BioLink Life Sciences, Inc BiomedInnovations LLC Blue Eye Soft Corp BlueRecruit, Inc. Bundle CAARMO CARL, Inc. CERCA CourtRoom5 Coworks Cytex Therapeutics, Inc. DataClarity Corporation DermiSense Inc Elevon EncepHEAL Therapeutics Equity Shift EternaTear FeedStation Floodlight Software Flow ROI Green Stream Technologies Inc Hank AI, Inc Home Lending Pal Intake LabVoice mesur.io, Inc Metallum3D Inc MicroElastic Ultrasound Systems MuukLabs MycoMed Technologies NALA Systems, Inc. Newsco Inc One Donation OpiAID, LLC PERMITS.com Phase Dock, Inc. PhosphoGam Plakous Therapeutics, Inc. Plan2Play Point Motion Inc. PrimeNeuro Protect3d Protopia QATCH Technologies Redbud Labs Reflekt Me, inc. RelayOne Renovian, Inc. Revibe Technologies Snthesis Inc Sparta BioMedical Inc. Squirrel Compliancy Solutions, Inc. Startomatic Sunder Networks Sweetie Pie Organics Swell Systems, Inc. Threat Sketch, LLC Trio Labs TRPBlue Inc. Tunnel International Inc URO-1, Inc. Venti LLC VitalFlo Inc. Xilis, Inc. Click here to view profiles. Register for Venture Connect Registration is OPEN and will run through March 11. Early ticket prices are $350 for entrepreneurs and $650 for General attendees. A ticket will include – three days of nonstop content, a keynote lunch, networking receptions, one-on-one meeting access, and more. Regular rates begin on February 15 and prices increase to $500 and $950 respectively, so get your tickets early! Visit the CED website to purchase tickets and for further information. The conference is presented in partnership with the North Carolina Biotechnology Center and the North Carolina Biosciences Organization. Media interested in attending the conference should contact Kristina Sandine at email@example.com or 919-226-0470.